tiprankstipranks
Trending News
More News >
Unilever (GB:ULVR)
LSE:ULVR

Unilever (ULVR) AI Stock Analysis

Compare
696 Followers

Top Page

GB:ULVR

Unilever

(LSE:ULVR)

Select Model
Select Model
Select Model
Outperform 71 (OpenAI - 5.2)
Rating:71Outperform
Price Target:
5,981.00p
▲(9.40% Upside)
Action:ReiteratedDate:02/18/26
The score is driven mainly by steady profitability and reliable free cash flow, tempered by higher leverage. Technicals are supportive (price above key averages, positive MACD) but appear overextended on RSI/Stoch. Valuation is somewhat demanding at ~22.7x earnings, while the ~3.44% dividend yield and earnings-call outlook (cautious growth guidance plus buyback and cash generation) provide support.
Positive Factors
Power Brands / Brand Strength
A concentrated portfolio of Power Brands driving most sales creates durable revenue resilience. With >78% of turnover from these brands and above-market volume growth, Unilever can focus marketing and BMI on winners, sustaining pricing power and repeat purchase behavior across channels.
Strong cash generation
Consistently strong free cash flow and meaningful cash conversion underpin long-term financial flexibility. This funds dividends, buybacks and productivity reinvestment while reducing leverage, supporting capital allocation and resilience during slower top-line periods or selective reinvestment cycles.
Margin expansion & productivity
Sustained margin expansion driven by productivity and gross-margin improvement indicates structural cost advantage. Delivering multi-hundred-million euro savings and allocating BMI to high-return Power Brands supports durable margin sustainability even amid selective input inflation.
Negative Factors
Elevated leverage
A capital structure skewed toward debt limits strategic optionality and raises sensitivity to higher rates or earnings shocks. Elevated leverage constrains M&A firepower and increases refinancing risk, making sustained deleveraging or stronger cash generation critical for long-term financial stability.
Uneven revenue growth
Volatile top-line trends signal exposure to cyclical demand, portfolio churn and regional mix shifts. Reliance on price over volumes in some years increases execution risk; inconsistent growth complicates planning and may pressure margins if volumes fail to recover broadly across categories.
FX & commodity exposure
Large emerging-market footprint creates persistent currency and input-cost risks. Material FX hits and concentrated commodity exposure can erode reported revenue and margins despite pricing action, requiring ongoing hedging, procurement scale and successful productivity to preserve profitability.

Unilever (ULVR) vs. iShares MSCI United Kingdom ETF (EWC)

Unilever Business Overview & Revenue Model

Company DescriptionUnilever PLC operates as a fast-moving consumer goods company. It operates through Beauty & Personal Care, Foods & Refreshment, and Home Care segments. The Beauty & Personal Care segment provides skin care and hair care products, deodorants, and skin cleansing products. The Foods & Refreshment segment offers ice cream, soups, bouillons, seasonings, mayonnaise, ketchups, and tea categories. The Home Care segment provides fabric solutions and various cleaning products. The company offers its products under the Domestos, OMO, Seventh Generation, Ben & Jerry's, Knorr, Magnum, Wall's, Bango, the Vegetarian Butcher, Axe, Cif, Comfort, Dove, Lifebuoy, Lux, Rexona, Sunsilk, Equilibra, OLLY, Liquid I.V., SmartyPants, Onnit, Hellmann's, and Vaseline brands. Unilever PLC was incorporated in 1894 and is headquartered in London, the United Kingdom.
How the Company Makes MoneyUnilever generates revenue through the sale of a vast array of consumer products across its various segments. The company's revenue model is primarily based on the direct sales of its brands to retailers and distributors, which then sell to end consumers. Key revenue streams include personal care products (such as skincare and oral care), home care products (cleaning agents and detergents), food and refreshments (packaged foods and beverages), and beauty and wellness items. Unilever also benefits from strong brand loyalty and a broad distribution network, which includes both traditional retail and e-commerce channels. Additionally, strategic partnerships and collaborations with retailers enhance market reach and visibility, contributing to overall sales growth. The company places a strong emphasis on sustainability and innovation, which helps differentiate its products in a competitive market and supports premium pricing strategies.

Unilever Earnings Call Summary

Earnings Call Date:Feb 12, 2026
(Q4-2025)
|
% Change Since: |
Next Earnings Date:Jul 23, 2026
Earnings Call Sentiment Neutral
The call presents a broadly positive operational and strategic story: volume-led growth, Power Brands outperformance, margin expansion, strong cash generation, active portfolio reshaping and a clear capital allocation framework. However, significant near-term headwinds persist from currency, regional softness (notably Latin America and China for the year), pockets of underperformance (non-Power Brands, certain Hair Care and Prestige assets), demerger-related costs and selective commodity inflation. Management guidance for 2026 is cautious (bottom end of the 4-6% multiyear range, volumes at least 2% and modest margin improvement), reflecting both confidence in the transformation and recognition of continuing external risks.
Q4-2025 Updates
Positive Updates
Group underlying sales growth and quarter-on-quarter improvement
Underlying sales growth of 3.5% for FY2025 (volumes +1.5%, price +2.0%) with clear sequential improvement into Q4: Q4 underlying sales growth 4.2% (volumes +2.1%, price +2.0%).
Power Brands outperformance
30 Power Brands (>78% of turnover) delivered 4.3% underlying sales growth for the full year (volumes +2.2%) and 2-year CAGR of 5% (volumes 3.4%); Q4 Power Brands growth stepped up to 5.8% (volumes +3.5%).
Strong Beauty & Wellbeing and Personal Care performance
Beauty & Wellbeing: underlying sales growth +4.3% (volume +2.2%, price +2.1%), underlying operating profit EUR 2.5bn with margin 19.2% (down 20bps). Personal Care: sales +4.7%, underlying operating profit EUR 3.0bn and margin 22.6% (up 50bps), driven by U.S. momentum and premium innovations (e.g., Dove, Vaseline, Liquid I.V., Nutrafol).
Foods delivered record margins and solid growth
Foods underlying sales growth +2.5% (volume +0.8%, price +1.7%); underlying operating profit EUR 2.9bn and underlying operating margin 22.6%, up 130 basis points to the highest level for the business group.
Home Care recovery and improvements
Home Care full-year sales +2.6% (volume-led +2.2%, price +0.4%) with Q4 acceleration to +4.7% (volumes +4.0%); underlying operating profit EUR 1.7bn and margin 14.9% (up 40bps).
Emerging markets momentum and notable market turnarounds
Emerging markets (59% of turnover) grew +3.5% for the year with Q4 acceleration to +5.8% (volumes +3.2%). Asia Pacific & Africa: +4.6% FY (volumes +3.0%) and Q4 +6.9% (volumes +5.7%). India FY +4.0% (volumes +3.0%), Q4 +5.0% (volumes +4.0%). Indonesia showed marked recovery with Q4 growth of ~17%.
Margin expansion, gross margin improvement and productivity
Group underlying operating margin expanded by 60 basis points to 20.0%. Gross margin expanded by 20 basis points to 46.9% (third consecutive year of expansion). Overheads improved by 50 basis points. Productivity program delivered >EUR 670m savings, with EUR 800m target on track for 2026.
Strong cash generation and improved leverage
Free cash flow EUR 5.9bn (100% cash conversion); excluding demerger items free cash flow ~EUR 6.3bn. Net debt down EUR 1.4bn to EUR 23.1bn and net debt / underlying EBITDA ~2.0x.
Capital allocation and shareholder returns
Returned EUR 6.0bn to shareholders in 2025 (EUR 4.5bn dividends, EUR 1.5bn buybacks). Announced new share buyback of EUR 1.5bn for 2026 and continued commitment to growing dividends. 100% of incremental brand & marketing investment (BMI) deployed behind Power Brands; BMI increased to 16.1% of turnover (up 10bps).
Earnings resilience on a constant currency basis
Underlying EPS EUR 3.08, up 0.7% reported and up 9.5% on a constant currency basis after a significant FX headwind.
Negative Updates
Significant currency headwinds and reported turnover decline
Turnover EUR 50.5bn, down 3.8% versus prior year driven by FX which reduced turnover by 5.9%; on a constant currency basis turnover increased by 2.3%.
Reported underlying operating profit and EPS compression from FX
Underlying operating profit declined 1.1% to EUR 10.1bn. Reported underlying EPS rose only 0.7% to EUR 3.08 with currency having a negative ~8.8% impact on EPS.
Latin America weakness and volume declines
Latin America underlying sales +0.5% for the year but volumes declined by 5.1% (price +5.9%) reflecting weak consumer demand and macro/political headwinds; region only returned to growth in Q4.
China flat for the year
China underlying sales were flat for FY2025 (though with mid-single-digit improvement in H2/Q4); management notes more work required on go-to-market and premiumization.
Hair Care mixed performance and specific market issues
Overall Hair Care was flat for the year (pricing offset lower volumes). Specific performance gaps noted in U.S. and Brazil Hair businesses and some Home Care/Deodorant format issues in Brazil requiring corrective actions.
Non-Power Brands underperformance and portfolio pruning effects
Non-Power Brands (≈22% of revenue) saw volume decline of ~1% for the year and accelerated to ~-3% in Q4. Portfolio disposals and discontinuations contributed a net negative portfolio impact (-1.2% net; disposals -1.8%, acquisitions +0.6%).
Free cash flow reduction from demerger-related costs and TSA uncertainties
Free cash flow was ~EUR 400m lower versus prior year due to Ice Cream demerger costs (separation-related tax on disposals); TSA (transition services) receipts/costs from the Magnum separation not quantified externally, creating short-term cash/fee uncertainty.
Commodity and inflationary pressures concentrated in key inputs
Management expects select commodity inflation in 2026 (notably palm oil, canola oil and surfactants) and ongoing wage inflation in some markets, posing margin and pricing pressure in Home Care and Personal Care.
Prestige & certain portfolio areas need further execution
Prestige Beauty is mixed: standout growth for some brands (Hourglass, K18) but underperformance/decline and channel issues for others (Dermalogica professional channel, Paula's Choice) requiring brand relaunches and execution fixes.
Company Guidance
The company guided 2026 underlying sales growth at the bottom end of its 4–6% multiyear range (c.4%), with underlying volume growth of at least 2% and a “modest” further improvement to underlying operating margin (2025 margin: 20%); it expects overall inflation to be lower than 2025 but selective commodity pressure (palm, canola, surfactants), currency headwinds that are heavier in H1, and continued reinvestment into brands. Capital allocation guidance included a new €1.5bn share buyback, continued attractive/growing dividends (in principle a 70:30 dividend:buyback balance), CapEx around ~3% of turnover (3.1% in 2025) with ~55–60% focused on productivity/margin initiatives, completion of the €800m productivity program (€670m delivered in 2025 with ~€130m remaining in 2026), and a commitment to strong cash generation/100% cash conversion and a balanced capital structure (net debt/EBITDA ~2x).

Unilever Financial Statement Overview

Summary
Profitability and free cash flow are solid (income statement 74; cash flow 71), supporting resilience and earnings quality. The main constraint is elevated leverage (balance sheet 58), which reduces flexibility if conditions weaken, and revenue growth has been uneven.
Income Statement
74
Positive
Profitability is solid and fairly resilient, with EBIT margin generally in the mid-to-high teens and net margin mostly around ~9%–13% (2025 net margin ~12.1%). Revenue growth has been uneven (declines in 2020 and 2023, modest growth in 2024, and a sharp rebound in 2025), which adds volatility to the topline outlook. A key data gap is 2025 gross profit and gross margin shown as 0, limiting visibility into the latest year’s product cost pressure vs. pricing power.
Balance Sheet
58
Neutral
Leverage is the main constraint: debt-to-equity is consistently elevated (roughly ~1.5–1.9), with 2025 at the high end (~1.91) alongside lower equity versus prior years, reducing balance-sheet flexibility. Total assets are stable, but the capital structure leans heavily toward debt financing, which can amplify risk if earnings weaken or rates stay higher. Strength is that profitability has been strong historically (return on equity was high in 2020–2024), though 2025 return on equity is not provided.
Cash Flow
71
Positive
Cash generation is consistently positive, with free cash flow running at a healthy portion of earnings (free cash flow to net income ~0.78–0.90 across years; 2025 ~0.82), indicating earnings quality is generally good. Free cash flow growth is volatile (notably down in 2021–2022 and 2024, then up in 2025), which suggests periodic working-capital swings or reinvestment variability. Operating cash flow relative to EBIT is moderate (~0.29–0.44), implying cash conversion is decent but not exceptionally strong.
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue49.59B60.76B59.60B60.07B52.44B
Gross Profit0.0027.37B25.18B24.17B22.18B
EBITDA11.11B11.74B11.99B13.07B10.82B
Net Income5.99B5.74B6.49B7.64B6.05B
Balance Sheet
Total Assets70.56B79.75B75.27B77.82B75.09B
Cash, Cash Equivalents and Short-Term Investments5.07B7.63B6.11B5.52B4.50B
Total Debt29.64B30.66B28.59B28.44B29.67B
Total Liabilities52.95B57.20B54.50B56.12B55.35B
Stockholders Equity15.55B19.99B18.10B19.02B17.11B
Cash Flow
Free Cash Flow6.39B7.55B7.68B5.66B6.73B
Operating Cash Flow7.78B9.52B9.43B7.28B7.97B
Investing Cash Flow-3.65B-625.00M-2.29B2.45B-3.25B
Financing Cash Flow-5.69B-6.94B-7.19B-8.89B-7.10B

Unilever Technical Analysis

Technical Analysis Sentiment
Positive
Last Price5467.00
Price Trends
50DMA
4976.00
Positive
100DMA
200DMA
Market Momentum
MACD
132.13
Positive
RSI
71.19
Negative
STOCH
41.66
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:ULVR, the sentiment is Positive. The current price of 5467 is above the 20-day moving average (MA) of 5277.01, above the 50-day MA of 4976.00, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of 132.13 indicates Positive momentum. The RSI at 71.19 is Negative, neither overbought nor oversold. The STOCH value of 41.66 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GB:ULVR.

Unilever Risk Analysis

Unilever disclosed 14 risk factors in its most recent earnings report. Unilever reported the most risks in the "Ability to Sell" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Unilever Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
76
Outperform
£1.70B12.939.47%1.62%0.50%20.52%
76
Outperform
£41.99B34.4217.41%3.44%-2.41%-16.41%
71
Outperform
£119.22B22.8728.78%3.85%-2.98%-16.90%
69
Neutral
£13.95B13.969.22%2.98%-3.06%-26.93%
66
Neutral
£36.96B20.3822.29%5.00%-2.83%-40.42%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
54
Neutral
£344.40M-70.78-2.51%4.82%-2.67%89.86%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
GB:ULVR
Unilever
5,467.00
656.85
13.66%
GB:DGE
Diageo
1,662.50
-445.82
-21.15%
GB:ABF
Associated British Foods
1,977.00
137.56
7.48%
GB:PFD
Premier Foods
197.40
17.16
9.52%
GB:PZC
PZ Cussons
82.10
3.56
4.53%
GB:RKT
Reckitt
6,512.00
1,446.58
28.56%

Unilever Corporate Events

Executive/Board ChangesRegulatory Filings and Compliance
Unilever Details Vesting of Performance Share Awards to Senior Leaders
Neutral
Feb 16, 2026

Unilever has disclosed a series of share awards vesting to senior executives under its performance share plan, reinforcing equity-based compensation as a core element of leadership pay. Chief Financial Officer Srinivas Phatak, several Unilever Leadership Executive members, and the CEO and Managing Director of Hindustan Unilever received vested ordinary shares or ADRs, in transactions dated 12 February and executed outside a trading venue.

The vesting, which spans home care, personal care, R&D, legal and the India business, aligns top management interests more closely with shareholders and signals ongoing use of long-term incentive structures. While the announcement is largely administrative, it underlines Unilever’s governance practice of publicly reporting transactions by persons discharging managerial responsibilities, an area closely watched by investors assessing alignment and potential signalling effects.

The most recent analyst rating on (GB:ULVR) stock is a Buy with a £60.00 price target. To see the full list of analyst forecasts on Unilever stock, see the GB:ULVR Stock Forecast page.

Executive/Board ChangesRegulatory Filings and Compliance
Unilever Discloses Vesting of Performance Share Awards to Senior Executives
Neutral
Feb 16, 2026

Unilever has disclosed multiple share transactions involving members of its senior leadership, following the vesting of performance share plan (PSP) awards in both London-listed ordinary shares and U.S.-traded ADRs. Executives including CFO Srinivas Phatak, Home Care President Eduardo Campanella, Chief R&D Officer Richard Slater, Chief Legal Officer Maria Varsellona, Hindustan Unilever CEO Priya Nair and Personal Care President Fabian Garcia all received shares off-market on 12 February, underscoring the company’s continued use of share-based remuneration to tie leadership compensation to equity performance and regulatory transparency requirements for PDMR dealings.

The most recent analyst rating on (GB:ULVR) stock is a Buy with a £60.00 price target. To see the full list of analyst forecasts on Unilever stock, see the GB:ULVR Stock Forecast page.

Executive/Board Changes
Unilever Discloses Expanded External Role for Senior Independent Director Susan Kilsby
Neutral
Feb 13, 2026

Unilever PLC disclosed a change in external responsibilities for one of its senior board members, underlining the continued prominence of its directors in international corporate leadership. The company reported that non-executive director Susan Kilsby, who also serves as Vice Chair and Senior Independent Director, is assuming expanded duties at another listed business.

Kilsby will become Executive Chair of Fortune Brands Innovations from 12 February 2026 and temporarily take on the functions of Chief Executive Officer between 1 April and 13 May 2026 during a defined transition period. Following that window, she will revert to her prior role as Chair of Fortune Brands Innovations, while retaining her existing non-executive and oversight responsibilities at Unilever, indicating continuity in Unilever’s board composition and governance structure.

The most recent analyst rating on (GB:ULVR) stock is a Buy with a £60.00 price target. To see the full list of analyst forecasts on Unilever stock, see the GB:ULVR Stock Forecast page.

Private Placements and FinancingRegulatory Filings and Compliance
Unilever Updates Documentation for U.S.$25 Billion Debt Issuance Programme
Neutral
Feb 12, 2026

Unilever has published a new FCA-approved supplement to its U.S.$25 billion debt issuance programme, covering Unilever Finance Netherlands B.V., Unilever Capital Corporation, and Unilever PLC as issuers, with Unilever PLC and Unilever United States, Inc. acting as guarantors. The supplement, which updates the existing information memorandum and related documentation for investors, underscores Unilever’s continued use of large-scale debt facilities as a financing tool, helping maintain flexibility in its capital structure and access to funding markets.

The updated documents have been made available via the London Stock Exchange’s document service and will also be stored in the FCA’s National Storage Mechanism for public inspection. This transparency in updating and filing programme documentation supports regulatory compliance and provides bond investors with current information on Unilever’s financing framework and related terms.

The most recent analyst rating on (GB:ULVR) stock is a Sell with a £4100.00 price target. To see the full list of analyst forecasts on Unilever stock, see the GB:ULVR Stock Forecast page.

Business Operations and StrategyStock BuybackDividendsFinancial DisclosuresM&A Transactions
Unilever lifts margins and reshapes portfolio as Ice Cream demerger completes
Positive
Feb 12, 2026

Unilever reported 2025 underlying sales growth of 3.5% driven by a 1.5% rise in volumes, resilient margins and strong contributions from its Power Brands, even as headline turnover declined due to currency headwinds and disposals. The group expanded its underlying operating margin to 20.0%, lifted earnings, generated robust free cash flow and raised its dividend while announcing a €1.5 billion share buyback.

Management accelerated portfolio reshaping by completing the demerger of the Ice Cream business and executing ten portfolio transactions, increasing exposure to Beauty & Wellbeing and Personal Care and exiting non-core food assets. Operational changes, including category-led sales structures and resets in Indonesia and China, underpinned stronger emerging-market performance and support guidance for modestly higher margins and low-end-of-range sales growth in 2026 despite slower markets.

The most recent analyst rating on (GB:ULVR) stock is a Hold with a £5150.00 price target. To see the full list of analyst forecasts on Unilever stock, see the GB:ULVR Stock Forecast page.

Business Operations and Strategy
Unilever Issues 4.2 Million New Shares to Satisfy Employee Share Awards
Neutral
Feb 5, 2026

Unilever PLC has issued and allotted 4,200,000 new ordinary shares of 3½ pence each to satisfy the vesting of awards under its employee share schemes, including the Unilever Share Plan 2017, the Unilever North America Omnibus Equity Compensation Plan, and the SHARES Plan. These new shares, admitted to trading on the London Stock Exchange’s Main Market under an existing block admission dated 14 March 2024, are fully fungible and will rank equally with the company’s existing ordinary shares, bringing the total number of issued ordinary shares to 2,185,205,247 and leaving 1,577,778 ordinary shares remaining under the block admission for future issuance.

The most recent analyst rating on (GB:ULVR) stock is a Buy with a £57.00 price target. To see the full list of analyst forecasts on Unilever stock, see the GB:ULVR Stock Forecast page.

Regulatory Filings and Compliance
Unilever Updates Share Capital and Voting Rights for Disclosure Purposes
Neutral
Feb 2, 2026

Unilever PLC has reported that, as of 30 January 2026, its issued share capital comprised 2,181,005,247 ordinary shares, of which 314,912 shares were held by Unilever group companies and carry no exercisable voting rights, leaving 2,180,690,335 shares with voting rights. The company stated that this voting-share figure should be used by investors as the reference denominator for calculating and disclosing their holdings or changes in holdings under UK disclosure and transparency rules, underscoring Unilever’s compliance with regulatory requirements and providing clarity for shareholders on the current voting rights base.

The most recent analyst rating on (GB:ULVR) stock is a Hold with a £5135.00 price target. To see the full list of analyst forecasts on Unilever stock, see the GB:ULVR Stock Forecast page.

Regulatory Filings and Compliance
Unilever Corrects Total Voting Rights Figure After Reporting Error
Neutral
Jan 8, 2026

Unilever PLC has issued a correction to its earlier disclosure on total voting rights, clarifying that as of 31 December 2025 the group held 314,912 ordinary shares (including those represented by ADSs), not 319,412 as previously stated. The company confirmed its issued share capital at 2,181,005,247 ordinary shares of 3.5p each, with no treasury shares and 2,180,690,335 shares carrying exercisable voting rights, a figure that shareholders should now use as the denominator for regulatory notifications of holdings under UK disclosure rules.

The most recent analyst rating on (GB:ULVR) stock is a Sell with a £4100.00 price target. To see the full list of analyst forecasts on Unilever stock, see the GB:ULVR Stock Forecast page.

Regulatory Filings and Compliance
Unilever Updates Share Capital and Voting Rights Ahead of FCA Disclosure Calculations
Neutral
Jan 2, 2026

Unilever PLC reported that as of 31 December 2025 its issued share capital comprised 2,181,005,247 ordinary shares, of which 319,412 were held by or on behalf of Unilever group companies and carry no exercisable voting rights, leaving 2,180,685,835 shares with voting rights outstanding. The company noted that this voting share figure will serve as the reference denominator for shareholders when calculating whether they must disclose their holdings or changes in holdings under UK Financial Conduct Authority transparency rules, providing clarity for investors and regulators on Unilever’s current capital and voting rights structure.

The most recent analyst rating on (GB:ULVR) stock is a Buy with a £5200.00 price target. To see the full list of analyst forecasts on Unilever stock, see the GB:ULVR Stock Forecast page.

Business Operations and StrategyDividends
Unilever Executives Reinvest Dividends in Company Shares
Positive
Dec 15, 2025

Unilever PLC has disclosed transactions involving its senior executives, including the reinvestment of dividends into company shares during an open trading period. These transactions, conducted on the London and Amsterdam Stock Exchanges, reflect the executives’ continued investment in Unilever, potentially signaling confidence in the company’s future performance and stability.

The most recent analyst rating on (GB:ULVR) stock is a Buy with a £5170.00 price target. To see the full list of analyst forecasts on Unilever stock, see the GB:ULVR Stock Forecast page.

Delistings and Listing Changes
Unilever Cancels Over 51 Million Treasury Shares
Neutral
Dec 11, 2025

Unilever PLC announced the cancellation of 51,625,153 ordinary shares held in treasury, reducing the total number of shares in issue to 2,181,005,247. This move leaves no shares held in treasury and adjusts the number of shares with voting rights to 2,180,690,335, impacting shareholder calculations under the UK Financial Conduct Authority’s rules.

The most recent analyst rating on (GB:ULVR) stock is a Sell with a £4440.00 price target. To see the full list of analyst forecasts on Unilever stock, see the GB:ULVR Stock Forecast page.

DividendsRegulatory Filings and Compliance
Unilever Updates Disclosure Practices for Dividend Equivalents
Negative
Dec 10, 2025

Unilever PLC announced a change in its disclosure approach regarding dividend equivalent rights on unvested share awards, stating it will no longer notify about the accrual of these dividends during the vesting period. This update impacts the transparency of financial transactions involving key executives, as notifications will now only occur when shares are acquired post-vesting, potentially affecting stakeholder insights into executive compensation.

The most recent analyst rating on (GB:ULVR) stock is a Sell with a £4440.00 price target. To see the full list of analyst forecasts on Unilever stock, see the GB:ULVR Stock Forecast page.

Business Operations and StrategyDelistings and Listing Changes
Unilever Completes Ice Cream Business Demerger and Announces Share Consolidation
Neutral
Dec 8, 2025

Unilever PLC has announced the completion of the demerger of its ice cream business and the subsequent consolidation of its ordinary shares, effective December 9, 2025. This share consolidation, which involves issuing 8 new shares for every 9 existing shares, is part of Unilever’s strategic restructuring to streamline operations and enhance shareholder value. The new shares will be listed on the London Stock Exchange and Euronext Amsterdam, with trading commencing on the same day. This move is expected to impact the company’s share capital and voting rights, with implications for shareholders and market positioning.

The most recent analyst rating on (GB:ULVR) stock is a Buy with a £50.50 price target. To see the full list of analyst forecasts on Unilever stock, see the GB:ULVR Stock Forecast page.

Business Operations and StrategyDelistings and Listing Changes
Unilever Completes Ice Cream Business Demerger and Announces Share Consolidation
Neutral
Dec 8, 2025

Unilever has completed the demerger of its ice cream business, which will now operate as The Magnum Ice Cream Company N.V. (TMICC). Shares of TMICC will begin trading on major stock exchanges, marking a significant restructuring move for Unilever. Additionally, Unilever is implementing a share consolidation to maintain share price comparability post-demerger, with new shares expected to commence trading shortly. This strategic move is likely to impact Unilever’s market positioning and shareholder value, reflecting its focus on streamlining operations and enhancing financial metrics.

The most recent analyst rating on (GB:ULVR) stock is a Buy with a £4946.00 price target. To see the full list of analyst forecasts on Unilever stock, see the GB:ULVR Stock Forecast page.

Business Operations and StrategyDelistings and Listing Changes
Unilever Completes Demerger of Ice Cream Business
Positive
Dec 5, 2025

Unilever has announced the completion of the demerger of its ice cream business, now named The Magnum Ice Cream Company N.V. (TMICC), set to be effective on December 6, 2025. TMICC shares will be listed and traded in Amsterdam, London, and New York starting December 8, 2025. This strategic move is accompanied by a share consolidation to maintain share price comparability, reflecting Unilever’s efforts to optimize its business structure and enhance shareholder value.

The most recent analyst rating on (GB:ULVR) stock is a Sell with a £4000.00 price target. To see the full list of analyst forecasts on Unilever stock, see the GB:ULVR Stock Forecast page.

Business Operations and StrategyStock Buyback
Unilever Cancels Over 13 Million Treasury Shares
Neutral
Dec 3, 2025

Unilever PLC announced the cancellation of 13,288,138 ordinary shares held in treasury, reducing the total number of shares in issue to 2,511,709,200. This move is part of Unilever’s ongoing efforts to manage its capital structure effectively, potentially impacting shareholder value and market perception.

The most recent analyst rating on (GB:ULVR) stock is a Sell with a £4120.00 price target. To see the full list of analyst forecasts on Unilever stock, see the GB:ULVR Stock Forecast page.

Regulatory Filings and Compliance
Unilever Updates Shareholders on Voting Rights and Capital Structure
Neutral
Dec 1, 2025

Unilever PLC announced an update on its voting rights and capital structure as of November 28, 2025. The company’s issued share capital consists of over 2.5 billion ordinary shares, with a portion held as treasury shares and by companies within the Unilever group, which do not carry voting rights. This update provides shareholders with the necessary information to assess their interests in Unilever PLC under the UK Financial Conduct Authority’s rules, impacting how they calculate and report changes in their shareholdings.

The most recent analyst rating on (GB:ULVR) stock is a Sell with a £4120.00 price target. To see the full list of analyst forecasts on Unilever stock, see the GB:ULVR Stock Forecast page.

Other
Unilever Director Acquires Company Shares
Positive
Nov 19, 2025

Unilever PLC has announced a transaction involving Zoe Yujnovich, a Non-Executive Director of the company, who has purchased 1,610 ordinary shares of Unilever PLC. The transaction, valued at £72,274.11, took place on November 18, 2025, on the London Stock Exchange, reflecting continued confidence in the company’s market position and potential for growth.

The most recent analyst rating on (GB:ULVR) stock is a Sell with a £4120.00 price target. To see the full list of analyst forecasts on Unilever stock, see the GB:ULVR Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 18, 2026